benefits from restructuring savings remain unchanged, and this yields an adjusted earnings per share range of $num-one to $num-two, an increase of num-three% to num-four% over last year.
earnings per share in the quarter was $num-one, which is up num-two%.
for xylem overall, we now see full-year year-six organic revenue growth in the range of num-one% to num-two%, up from our previous guidance of num-three% to num-one%.